Click for best price
Hepatitis B Treatment Market Size, Share 2022
It means a treatment of Hepatitis B?? contagious liver infection that can be long lasting.
This report contains market size and forecasts of Hepatitis B Treatment in Global, including the following market information:
Global Hepatitis B Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acute Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Treatment include Accord Healthcare Inc., Apotex Corp., Arbutus Biopharma, Bristol-Myers Squibb Company, Gilead Sciences, GlaxoSmithKline, Lupin Pharmaceuticals, Merck & Co., Inc. and Par Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Treatment Market Segment Percentages, by Type, 2021 (%)
Acute
Chronic
Global Hepatitis B Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Treatment Market Segment Percentages, by Application, 2021 (%)
Immune Modulator Drugs
Antiviral Drugs
Global Hepatitis B Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accord Healthcare Inc.
Apotex Corp.
Arbutus Biopharma
Bristol-Myers Squibb Company
Gilead Sciences
GlaxoSmithKline
Lupin Pharmaceuticals
Merck & Co., Inc.
Par Pharmaceutical
Teva Pharmaceuticals
Zydus Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Treatment Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Treatment Overall Market Size
2.1 Global Hepatitis B Treatment Market Size: 2021 VS 2028
2.2 Global Hepatitis B Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B Treatment Players in Global Market
3.2 Top Global Hepatitis B Treatment Companies Ranked by Revenue
3.3 Global Hepatitis B Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatitis B Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatitis B Treatment Market Size Markets, 2021 & 2028
4.1.2 Acute
4.1.3 Chronic
4.2 By Type - Global Hepatitis B Treatment Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Treatment Revenue, 2017-2022
4.2.2 By Type - Global Hepatitis B Treatment Revenue, 2023-2028
4.2.3 By Type - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Treatment Market Size, 2021 & 2028
5.1.2 Immune Modulator Drugs
5.1.3 Antiviral Drugs
5.2 By Application - Global Hepatitis B Treatment Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Treatment Revenue, 2017-2022
5.2.2 By Application - Global Hepatitis B Treatment Revenue, 2023-2028
5.2.3 By Application - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatitis B Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hepatitis B Treatment Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Treatment Revenue, 2017-2022
6.2.2 By Region - Global Hepatitis B Treatment Revenue, 2023-2028
6.2.3 By Region - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatitis B Treatment Revenue, 2017-2028
6.3.2 US Hepatitis B Treatment Market Size, 2017-2028
6.3.3 Canada Hepatitis B Treatment Market Size, 2017-2028
6.3.4 Mexico Hepatitis B Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatitis B Treatment Revenue, 2017-2028
6.4.2 Germany Hepatitis B Treatment Market Size, 2017-2028
6.4.3 France Hepatitis B Treatment Market Size, 2017-2028
6.4.4 U.K. Hepatitis B Treatment Market Size, 2017-2028
6.4.5 Italy Hepatitis B Treatment Market Size, 2017-2028
6.4.6 Russia Hepatitis B Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Hepatitis B Treatment Market Size, 2017-2028
6.4.8 Benelux Hepatitis B Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatitis B Treatment Revenue, 2017-2028
6.5.2 China Hepatitis B Treatment Market Size, 2017-2028
6.5.3 Japan Hepatitis B Treatment Market Size, 2017-2028
6.5.4 South Korea Hepatitis B Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Hepatitis B Treatment Market Size, 2017-2028
6.5.6 India Hepatitis B Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatitis B Treatment Revenue, 2017-2028
6.6.2 Brazil Hepatitis B Treatment Market Size, 2017-2028
6.6.3 Argentina Hepatitis B Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B Treatment Revenue, 2017-2028
6.7.2 Turkey Hepatitis B Treatment Market Size, 2017-2028
6.7.3 Israel Hepatitis B Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatitis B Treatment Market Size, 2017-2028
6.7.5 UAE Hepatitis B Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Accord Healthcare Inc.
7.1.1 Accord Healthcare Inc. Corporate Summary
7.1.2 Accord Healthcare Inc. Business Overview
7.1.3 Accord Healthcare Inc. Hepatitis B Treatment Major Product Offerings
7.1.4 Accord Healthcare Inc. Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.1.5 Accord Healthcare Inc. Key News
7.2 Apotex Corp.
7.2.1 Apotex Corp. Corporate Summary
7.2.2 Apotex Corp. Business Overview
7.2.3 Apotex Corp. Hepatitis B Treatment Major Product Offerings
7.2.4 Apotex Corp. Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.2.5 Apotex Corp. Key News
7.3 Arbutus Biopharma
7.3.1 Arbutus Biopharma Corporate Summary
7.3.2 Arbutus Biopharma Business Overview
7.3.3 Arbutus Biopharma Hepatitis B Treatment Major Product Offerings
7.3.4 Arbutus Biopharma Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.3.5 Arbutus Biopharma Key News
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Corporate Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Hepatitis B Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.4.5 Bristol-Myers Squibb Company Key News
7.5 Gilead Sciences
7.5.1 Gilead Sciences Corporate Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Hepatitis B Treatment Major Product Offerings
7.5.4 Gilead Sciences Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.5.5 Gilead Sciences Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Hepatitis B Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
7.7 Lupin Pharmaceuticals
7.7.1 Lupin Pharmaceuticals Corporate Summary
7.7.2 Lupin Pharmaceuticals Business Overview
7.7.3 Lupin Pharmaceuticals Hepatitis B Treatment Major Product Offerings
7.7.4 Lupin Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.7.5 Lupin Pharmaceuticals Key News
7.8 Merck & Co., Inc.
7.8.1 Merck & Co., Inc. Corporate Summary
7.8.2 Merck & Co., Inc. Business Overview
7.8.3 Merck & Co., Inc. Hepatitis B Treatment Major Product Offerings
7.8.4 Merck & Co., Inc. Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.8.5 Merck & Co., Inc. Key News
7.9 Par Pharmaceutical
7.9.1 Par Pharmaceutical Corporate Summary
7.9.2 Par Pharmaceutical Business Overview
7.9.3 Par Pharmaceutical Hepatitis B Treatment Major Product Offerings
7.9.4 Par Pharmaceutical Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.9.5 Par Pharmaceutical Key News
7.10 Teva Pharmaceuticals
7.10.1 Teva Pharmaceuticals Corporate Summary
7.10.2 Teva Pharmaceuticals Business Overview
7.10.3 Teva Pharmaceuticals Hepatitis B Treatment Major Product Offerings
7.10.4 Teva Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.10.5 Teva Pharmaceuticals Key News
7.11 Zydus Pharmaceuticals
7.11.1 Zydus Pharmaceuticals Corporate Summary
7.11.2 Zydus Pharmaceuticals Business Overview
7.11.3 Zydus Pharmaceuticals Hepatitis B Treatment Major Product Offerings
7.11.4 Zydus Pharmaceuticals Hepatitis B Treatment Revenue in Global Market (2017-2022)
7.11.5 Zydus Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B Treatment Market Opportunities & Trends in Global Market
Table 2. Hepatitis B Treatment Market Drivers in Global Market
Table 3. Hepatitis B Treatment Market Restraints in Global Market
Table 4. Key Players of Hepatitis B Treatment in Global Market
Table 5. Top Hepatitis B Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatitis B Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatitis B Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatitis B Treatment Product Type
Table 9. List of Global Tier 1 Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatitis B Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatitis B Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatitis B Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatitis B Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Hepatitis B Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatitis B Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatitis B Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatitis B Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatitis B Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Accord Healthcare Inc. Corporate Summary
Table 31. Accord Healthcare Inc. Hepatitis B Treatment Product Offerings
Table 32. Accord Healthcare Inc. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Apotex Corp. Corporate Summary
Table 34. Apotex Corp. Hepatitis B Treatment Product Offerings
Table 35. Apotex Corp. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Arbutus Biopharma Corporate Summary
Table 37. Arbutus Biopharma Hepatitis B Treatment Product Offerings
Table 38. Arbutus Biopharma Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Company Corporate Summary
Table 40. Bristol-Myers Squibb Company Hepatitis B Treatment Product Offerings
Table 41. Bristol-Myers Squibb Company Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Gilead Sciences Corporate Summary
Table 43. Gilead Sciences Hepatitis B Treatment Product Offerings
Table 44. Gilead Sciences Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Hepatitis B Treatment Product Offerings
Table 47. GlaxoSmithKline Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Lupin Pharmaceuticals Corporate Summary
Table 49. Lupin Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 50. Lupin Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck & Co., Inc. Corporate Summary
Table 52. Merck & Co., Inc. Hepatitis B Treatment Product Offerings
Table 53. Merck & Co., Inc. Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Par Pharmaceutical Corporate Summary
Table 55. Par Pharmaceutical Hepatitis B Treatment Product Offerings
Table 56. Par Pharmaceutical Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceuticals Corporate Summary
Table 58. Teva Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 59. Teva Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Zydus Pharmaceuticals Corporate Summary
Table 61. Zydus Pharmaceuticals Hepatitis B Treatment Product Offerings
Table 62. Zydus Pharmaceuticals Hepatitis B Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatitis B Treatment Segment by Type in 2021
Figure 2. Hepatitis B Treatment Segment by Application in 2021
Figure 3. Global Hepatitis B Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatitis B Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B Treatment Revenue in 2021
Figure 8. By Type - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 12. US Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 24. China Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatitis B Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatitis B Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Accord Healthcare Inc. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Apotex Corp. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arbutus Biopharma Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Company Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Gilead Sciences Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lupin Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck & Co., Inc. Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Par Pharmaceutical Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Zydus Pharmaceuticals Hepatitis B Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
